Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum
Top Cited Papers
Open Access
- 10 June 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Abstract
MicroRNAs (miRNAs) play essential roles in post-transcriptional gene expression and are also found freely circulating in bodily fluids such as blood. Dysregulated miRNA signatures have been associated with many diseases including cancer, and miRNA profiling from liquid biopsies offers a promising strategy for cancer diagnosis, prognosis and monitoring. Here, we develop size-encoded molecular probes that can be used for simultaneous electro-optical nanopore sensing of miRNAs, allowing for ultrasensitive, sequence-specific and multiplexed detection directly in unprocessed human serum, in sample volumes as small as 0.1 μl. We show that this approach allows for femtomolar sensitivity and single-base mismatch selectivity. We demonstrate the ability to simultaneously monitor miRNAs (miR-141-3p and miR-375-3p) from prostate cancer patients with active disease and in remission. This technology can pave the way for next generation of minimally invasive diagnostic and companion diagnostic tests for cancer.Keywords
This publication has 61 references indexed in Scilit:
- Exploration of miRNA families for hypotheses generationScientific Reports, 2013
- A Review on the Clinical Utility of PSA in Cancer ProstateIndian Journal of Surgical Oncology, 2012
- Nanopore-based detection of circulating microRNAs in lung cancer patientsNature Nanotechnology, 2011
- Regulation of mRNA Translation and Stability by microRNAsAnnual Review of Biochemistry, 2010
- Electrostatic focusing of unlabelled DNA into nanoscale pores using a salt gradientNature Nanotechnology, 2009
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- DNA Translocation Governed by Interactions with Solid-State NanoporesBiophysical Journal, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancerGynecologic Oncology, 2008
- A single-molecule method for the quantitation of microRNA gene expressionNature Methods, 2005